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Background: Conflicting data exist regarding the safety of pancreatic resections in elderly patients. In
this study we compared early complication and mortality rates between patients younger and older than
80 years of age who underwent pancreaticoduodenectomy using a validated national database.
Methods: The National Surgical Quality Improvement Program (NSQIP) database for 2005–2009 was
used for this retrospective analysis. The primary outcome measures for our analysis were 30-day
postoperative mortality, major complication rate and overall complication rate.
Results: A total of 6293 patients who underwent PD for any cause were included in the analysis. Of
these, 9.4% were aged 80 years. The incidence of 30-day mortality was significantly higher in patients
aged 80 years (6.3%) than in those aged <80 years (2.7%). Older patients were also noted to have
higher rates of overall complications and serious complications. On multivariate analysis, age, ASA
(American Society of Anesthesiologists) classification, reduced functional status, history of dyspnoea,
and need for intraoperative transfusion were risk factors associated with the occurrence of overall
complications, serious complications and postoperative mortality.
Conclusions: This study shows that age among other factors is a determinant of postoperative mor-
bidity and mortality following PD.
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Introduction
Pancreatic cancer is a disease that predominantly affects elderly
people with a mean age at diagnosis of 72 years. Approximately
29% of patients with the disease are aged 75–84 years, and 13% are
aged 85 years at the time of diagnosis.1 According to the Sur-
veillance, Epidemiology and End Results (SEER) Program, during
2003–2007 the median age at death from cancer of the pancreas in
the USA was 73 years and approximately 30% of deaths occurred
in patients aged 75–84 years, while 15% occurred in patients aged
85 years.2 When therapy-associated mortality is taken into con-
sideration, these rates increase even further. Despite recent new
advances in chemotherapeutic regimens for advanced pancreatic
cancers,3,4 complete surgical resection continues to represent the
only chance for cure. Pancreaticoduodenectomy (PD) is also per-
formed in selected patients with chronic pancreatitis limited to
the head of the gland.
Because of the increasing age of the general population, aggres-
sive therapy is often offered to patients in the last years of their
lives. However, previous studies have found conflicting results
regarding morbidity and mortality associated with PD in elderly
patients.5,6 Proponents of surgical resection in the elderly popula-
tion have found immediate postoperative complication rates
similar to those in younger patients and comparable survival
benefits.7–9 Others have shown that elderly patients have a ten-
dency to stay longer in the intensive care unit (ICU) following PD,
have higher incidences of postoperative cardiac events, experience
more nutritional and functional difficulties, and require more
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readmissions compared with younger patients.5,10 The purpose of
the present study was to compare early complication and mortal-
ity rates between patients younger and older than 80 years of age
who underwent PD for any cause. This research was accomplished
using the database of the American College of Surgeons (ACS)
National Surgical Quality Improvement Program (NSQIP), a
nationally validated, outcomes-based project that quantifies
30-day risk-adjusted surgical outcomes at more than 200 hospitals
across the USA.
Materials and methods
The NSQIP Participant User Files (NSQIP-PUF) for 2005–2009
were used for this retrospective analysis. Patients with a primary
current procedural terminology (CPT) code for PD (CPT codes
48150, 48152, 48153 and 48154) were included for analysis. All PD
procedures reported to the NSQIP were included in our study;
analysis of the data was not limited to those procedures performed
for oncologic reasons. The primary outcome measures were
30-day postoperative mortality, major complication rate and
overall complication rate, as reported by other authors.11 For
analysis purposes, patients were considered to have sustained a
major postoperative complication if they developed one or more
of the following: organ/space surgical site infection; wound dehis-
cence; postoperative neurologic deficit (including stroke or coma
for >24 h); cardiac arrest requiring cardiopulmonary resuscitation
(CPR); myocardial infarction; bleeding requiring transfusion;
pulmonary embolism; ventilator dependence for >48 h; progres-
sive renal insufficiency; acute renal failure; and sepsis or septic
shock. Patients were considered to have suffered any complication
if they developed one or more of the following: a major compli-
cation (as defined above); superficial surgical site infection; deep
surgical site infection; pneumonia; unplanned intubation; periph-
eral nerve injury; urinary tract infection; and deep venous throm-
bosis. Secondary outcome measures included the incidence of
individual postoperative complications, need for reoperation,
incidence and volume of intraoperative packed red blood cell
(PRBC) transfusion, and postoperative length of hospital stay.
The primary predictor variable for our analysis was patient age,
which was treated as a dichotomous variable (<80 years, 80
years). In the NSQIP-PUF, age is top-coded at 90 years. Other
predictor variables included: female gender; body mass index
>30 kg/m2; American Society of Anesthesiologists (ASA) classifi-
cation of 3; diabetes mellitus requiring therapy with non-
insulin agents or insulin; smoking within 1 year of the operation;
consumption of more than two drinks of ethanol per day in the 2
weeks prior to admission; dyspnoea upon moderate exertion or at
rest; partially or totally dependent functional status prior to
surgery (see definition below); chronic obstructive pulmonary
disease (COPD); coronary artery disease (including history of
myocardial infarction within the past 6 months, prior percutane-
ous coronary intervention, prior cardiac surgery and/or history of
angina within 30 days prior to surgery); peripheral vascular
disease (including history of revascularization or amputation for
peripheral vascular disease and/or rest pain or gangrene); renal
disease (including acute renal failure within 24 h prior to surgery
and/or need for dialysis within 2 weeks prior to surgery);
neurologic disease (including impaired sensorium, coma,
hemiplegia/hemiparesis, history of transient ischaemic attacks,
stroke with neurologic deficit, tumour involving the central
nervous system, paraplegia/paraparesis and/or quadriplegia/
quadraparesis); steroid use within 30 days prior to surgery for a
chronic medical condition; chemotherapy for malignancy within
30 days prior to surgery; radiotherapy for malignancy within 90
days prior to surgery; need for intraoperative transfusion; and
inclusion of pancreaticojejunostomy during PD (as indicated by
CPT codes 48150 and 48153).
The NSQIP defines functional health status according to the
patient’s ability to perform activities of daily living (ADLs) during
the 30 days prior to surgery. Activities of daily living include:
bathing, feeding, toileting, and being mobile. The level of func-
tional health status is defined by the following criteria and
reported to the NSQIP as:
1 Independent: the patient does not require assistance from
another person to fulfil any ADLs. This includes a person who
is able to function independently using prosthetics, equipment
or devices;
2 Partially dependent: the patient requires some assistance from
another person to fulfil ADLs. This includes a person who uti-
lizes prosthetics, equipment or devices but still requires some
assistance from another person;
3 Totally dependent: the patient requires total assistance to fulfil
all ADLs;
4 Unknown: patients whose functional status prior to surgery is
not ascertained are reported as of unknown functional status.
For analysis purposes, patients who were either partially or
totally dependent were considered to have reduced functional
status in this study.
Preoperative and intraoperative characteristics of patients aged
<80 years and patients aged80 years were compared using Pear-
son’s chi-squared tests for categorical variables, unpaired two-
sided Student’s t-tests for normally distributed continuous
variables, and Mann–Whitney rank sum tests for non-parametric
continuous variables. For each primary outcome measure, a
forward stepwise multivariate logistic regression model was devel-
oped using the previously described predictor variables. The
P-value for entry of a variable into each model was < 0.05 and the
primary predictor variable was forced into each model regardless
of the significance of its association with the outcome measure on
univariate analysis. Comparisons of secondary outcome measures
in patients aged <80 years and patients aged 80 years, respec-
tively, were performed using unpaired two-sided Student’s t-tests
for normally distributed continuous variables and Mann–
Whitney rank sum tests for non-parametric continuous variables.
stata Version 11.0 (StataCorp LP, College Station, TX, USA) was
used for all statistical analyses.
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Results
A total of 6293 patients who underwent PD were included in the
final analysis. Of these, 593 patients (9.4%) were aged 80 years
(median age: 82.9 2.6 years). There were no differences in racial
distributions between the groups and the majority of patients
were White. There were no differences between groups in the
number of patients with diabetes mellitus, COPD, peripheral vas-
cular disease or neurologic disorder, the number of patients who
received chemotherapy within 30 days or radiation therapy within
90 days prior to surgery, or the number of patients using steroids.
Other demographic characteristics and preoperative variables for
which statistically significant differences were found between
groups are shown in Table 1.
The incidence of 30-day mortality was higher in patients aged
80 years (6.3%) than in those aged <80 years (2.7%) (P < 0.05).
Older patients were also noted to have higher rates of overall
complications (45.2% vs. 35.8%; P < 0.05) and serious complica-
tions (32.2% vs. 24%; P < 0.05). Elderly patients had significantly
higher rates of wound dehiscence, pneumonia, unplanned intu-
bation, prolonged respiratory support, urinary tract infections,
septic shock, cardiac arrest requiring CPR and myocardial
infarction (Table 2). These patients also required more intraop-
erative transfusions; however, the number of PRBC units trans-
fused was similar in each group. Younger patients had a
significantly shorter median postoperative hospital stay than their
older counterparts (9 days vs. 11 days; P < 0.05). Complications
which occurred at similar frequencies in both groups included
stroke, coma for >24 h, peripheral nerve injury, deep venous
thrombosis, sepsis, superficial surgical site infection, deep surgical
site infection, organ/space surgical site infection, pulmonary
embolism, progressive renal insufficiency and acute renal failure.
Table 1 Demographic and preoperative characteristics of patients undergoing pancreaticoduodenectomy (n = 6293) according to age
Age: <80 years
(n = 5700)
Age: 80 years
(n = 593)
P-valuea
Male gender, n (%) 2931 (48.7%) 332 (53.2%) 0.03
Body mass index > 30, n (%) 1455 (24.2%) 78 (12.5%) <0.0001
ASA classification  3, n (%) 4089 (68.0%) 511 (82.0%) <0.0001
Tobacco use, n (%) 1447 (24.1%) 33 (5.3%) <0.0001
Ethanol use, n (%) 224 (3.7%) 10 (1.6%) 0.006
Reduced functional status, n (%) 159 (2.6%) 38 (6.1%) <0.0001
Dyspnoea, n (%) 499 (8.3%) 83 (13.3%) <0.0001
Coronary artery disease, n (%) 649 (10.8%) 112 (18.0%) <0.0001
Hypertension, n (%) 3007 (50.0%) 455 (72.9%) <0.0001
Renal insufficiency/failure, n (%) 25 (0.4%) 9 (1.4%) 0.001
Bleeding disorder, n (%) 141 (2.3%) 29 (4.7%) 0.001
aP < 0.05 was considered to indicate significance.
ASA, American Society of Anesthesiologists.
Table 2 Differences in postoperative complications and outcomes in patients undergoing pancreaticoduodenectomy according to age
Age: < 80 years
(n = 5700)
Age:  80 years
(n = 593)
P-valuea
Specific complication
Wound dehiscence 102 (1.7%) 24 (3.9%) <0.0001
Pneumonia 329 (5.5%) 49 (7.9%) 0.01
Unplanned intubation 295 (4.9%) 56 (9.0%) <0.0001
Prolonged ventilator support 342 (5.7%) 60 (9.6%) <0.0001
Urinary tract infection 331 (5.5%) 56 (9.0%) <0.0001
Septic shock 286 (4.8%) 45 (7.2%) 0.007
Cardiac arrest requiring CPR 75 (1.3%) 14 (2.2%) 0.04
Myocardial infarction 26 (0.4%) 7 (1.1%) 0.02
Operative time, min, mean  SD 377.5  127.8 344.2  109.4 <0.0001
Required intraoperative transfusion 1810 (30.1%) 250 (40.1%) <0.0001
Postoperative length of stay, days, median 9 (range: 7–14) 11 (range: 8–18) <0.0001
aP < 0.05 was considered to indicate significance.
CPR, cardiopulmonary resuscitation; SD, standard deviation.
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The percentage of patients who required re-exploration was also
similar in both groups.
On multivariate analysis, age was noted to be a significant risk
factor for the occurrence of overall and serious complications, as
well as for postoperative mortality (Tables 3–5). Other factors
found to be predictors of complications and mortality included
ASA class of 3, reduced functional status, history of dyspnoea,
coronary artery disease, and history of intraoperative transfusions
(Tables 3, 4). Risk factors that were predictors of any complication
following PD are shown in Table 5. Female gender was found to be
protective against both major [odds ratio (OR) 0.8, 95% confi-
dence interval (CI) 0.71–0.90] and any (OR 0.89, 95% CI 0.80–
0.99) complications after PD on multivariate analysis. The reasons
for this are unclear.
Discussion
Contrary to previous studies that have reported age not to be an
independent risk factor in patients undergoing PD,12,13 our analy-
sis of data sourced from a large national database shows that
patients aged80 years have a significantly higher risk for 30-day
morbidity and mortality compared with younger patients. On
multivariate analysis, age, ASA classification, reduced functional
status, history of dyspnoea and need for intraoperative transfu-
sion were found to be predictors of the occurrence of overall
complications, serious complications and 30-day mortality. In
concert with the findings of other authors,14,15 our analysis shows
that the need for intraoperative transfusions in patients undergo-
ing PD is associated with poor postoperative outcomes. The
higher incidence of intraoperative transfusions in the elderly
group is not necessarily a sign of bleeding, poor surgical perfor-
mance or tumour-related factors, but is more likely to be related to
the higher incidence of baseline chronic diseases such as bleeding
disorders and coronary artery disease in this population.
In elderly patients who present with pancreatic pathology such
as pancreatic head masses, multiple factors should be considered
before aggressive therapeutic protocols that include major surgical
intervention are embarked upon. These patients typically use
multiple medications that frequently must be continued during
the postoperative period. Older patients tend to have a prior
history of cardiac disease that requires close postoperative moni-
toring, and their nutritional status should be determined preop-
eratively because nutritional de-conditioning has been associated
with poor postoperative outcomes after pancreatic resection.16
Patients who are not completely dependent or whose ADL status,
‘as defined’ in this paper as decreased functional status, are at
higher risk for the occurrence of postoperative complications and
increased mortality. Indeed, multivariate analysis of our dataset
showed that decreased functional status has the greatest predictive
value for postoperative mortality after PD.
Although such factors are more common in elderly patients,
most experts would not consider age alone to be a contraindica-
tion for PD based on the data available to date. In a recent retro-
spective study, Sohn et al. showed similar rates of longterm
survival in younger and older patients undergoing PD for onco-
logic reasons.17 However, in the present study, patients in the older
group were found to have a longer postoperative length of stay
and a higher rate of complications than younger patients. Accord-
ing to Sohn et al., PD resulted in a perioperative mortality rate of
4.3% in the older group compared with 1.6% in the younger
group, but the difference between these rates was not statistically
significant.17
The use of a national validated database such as the ACS-
NSQIP offers an incomparable opportunity to determine postop-
erative outcomes in a large number of patients treated at a variety
of centres. Only recently, the NSQIP incorporated a procedure-
targeted option that allows for the capture of hepatobiliary-
specific outcomes in hundreds of patients.18 A current limitation
of the database and thus an inherent limitation of our study is the
lack of information regarding frequent pancreas-related postop-
erative complications such as anastomotic leak, development of
pancreatic fistula or delayed gastric emptying. Other limitations
of the NSQIP and consequently of our study relate to the retro-
spective nature of the database. Most NSQIP data are collected by
surgical clinical nurse reviewers, who abstract the medical record
at the completion of the surgical portion of care.19
However, these restrictions have not prevented authors from
using the database to establish risk calculators for patients under-
going pancreatic resection. A study by Parikh et al., using the
NSQIP database of patients who underwent all types of pancreatic
resection, showed that risk factors for postoperative morbidity
and mortality included age >74 years, male gender, BMI > 40 kg/
m2, preoperative sepsis, dependent functional status, ASA class >2,
history of coronary heart disease, dyspnoea on moderate exertion,
a bleeding disorder, and the contemplated procedure.20 These
findings are similar to ours in that advanced age, decreased func-
tional status and need for intraoperative blood transfusion are
associated with worse outcomes. However, Parikh et al.20 included
all pancreatic resections rather than focusing on PD only, as our
study did. In addition, the study by Parikh et al.20 was specifically
Table 3 Predictors of postoperative death after pancreaticoduo-
denectomy on multivariate analysis (using forward stepwise
regression)
Predictor variable Adjusted
OR
95% CI P-valuea
Age  80 years 1.63 1.12–2.39 0.01
ASA classification  3 2.39 1.50–3.79 <0.0001
Reduced functional status 2.80 2.73–4.51 <0.0001
Dyspnoea 1.82 1.24–2.66 0.002
Coronary artery disease 1.46 1.02–2.10 0.04
Hypertension 1.50 1.08–2.08 0.015
Intraoperative transfusion 1.91 1.42–2.57 <0.0001
aP < 0.05 was considered to indicate significance.
OR, odds ratio; 95% CI, 95% confidence interval; ASA, American Society
of Anesthesiologists.
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designed to construct a risk calculator for pancreatic resections
and not to compare outcomes between age groups.
Prior studies have shown that outcomes following pancreatic
resections are related, at least partially, to the number of cases
performed annually at a specific centre.21 Although our analysis
did not distinguish between low- and high-volume institutions,
the management of elderly patients requires a full understanding
of all aspects of health care that affect the geriatric population22
and high-volume institutions often provide resources for these
patients that lower-volume hospitals may not have available. The
establishment of standards of quality for elderly patients should
allow this population to be treated similarly to younger patients.23
A recent analysis of SEER–Medicare linked data demonstrated
that, in patients with locoregional pancreatic cancer, the likeli-
hood of being evaluated by a surgeon decreased by 8% with each
increasing year of age, and a decrease in surgical resection rates
was noted regardless of patient comorbidities.24 Even in patients
without comorbidities, resection rates decreased from 40% in
patients aged 66–70 years, to 37% in those aged 70–74 years, 32%
in those aged 75–79 years, 21% in those aged 80–84 years, to only
7% in patients aged 85 years. Whether these findings demon-
strate the reluctance of surgeons to offer PD to elderly patients or
the preconceptions of primary doctors who refer these patients for
surgical excision is not clear.
In conclusion, the analysis of a nationally validated database
shows increased morbidity and mortality rates in elderly patients
undergoing PD for any cause. In this study, reduced functional
status was found to have the greatest predictive value for postop-
erative mortality after PD. Other factors affecting outcomes
include ASA classification, history of dyspnoea and need for intra-
operative transfusions. The referral of elderly patients to centres
which have dedicated geriatric services is advisable when possible.
Age and functional status should be taken into consideration
when counselling patients on the morbidity and mortality asso-
ciated with this operation.
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